Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−410KRW
−31.33 BKRW
125.93 BKRW
42.71 M
About BUKWANG PHARMACEUTICAL
Sector
Headquarters
Seoul
Employees (FY)
607
Website
Founded
1960
ISIN
KR7003000007
FIGI
BBG000BGY566
Bukwang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include gastrointestinal, central nervous system, metabolic drugs and others such as houlsehold suppiles and gift sets. The company was founded on October 17, 1960 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 003000 is 5670 KRW — it has decreased by 0.87% in the past 24 hours. Watch BUKWANG PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BUKWANG PHARMACEUTICAL stocks are traded under the ticker 003000.
003000 stock has fallen by 1.56% compared to the previous week, the month change is a 14.74% fall, over the last year BUKWANG PHARMACEUTICAL has showed a 24.20% decrease.
003000 reached its all-time high on Jul 21, 2020 with the price of 42320 KRW, and its all-time low was 1430 KRW and was reached on Oct 24, 2003. View more price dynamics on 003000 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
003000 stock is 1.60% volatile and has beta coefficient of 0.51. Track BUKWANG PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is BUKWANG PHARMACEUTICAL there?
Today BUKWANG PHARMACEUTICAL has the market capitalization of 377.30 B, it has increased by 0.69% over the last week.
Yes, you can track BUKWANG PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
BUKWANG PHARMACEUTICAL is going to release the next earnings report on Aug 14, 2024. Keep track of upcoming events with our Earnings Calendar.
003000 net income for the last quarter is −1.91 B KRW, while the quarter before that showed −10.80 B KRW of net income which accounts for 82.30% change. Track more BUKWANG PHARMACEUTICAL financial stats to get the full picture.
As of Jun 14, 2024, the company has 607.00 employees. See our rating of the largest employees — is BUKWANG PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BUKWANG PHARMACEUTICAL EBITDA is −30.22 B KRW, and current EBITDA margin is −26.37%. See more stats in BUKWANG PHARMACEUTICAL financial statements.
Like other stocks, 003000 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BUKWANG PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BUKWANG PHARMACEUTICAL technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BUKWANG PHARMACEUTICAL stock shows the strong sell signal. See more of BUKWANG PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.